Meridian Investment Counsel’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-4,200
| Closed | -$356K | – | 181 |
|
|
2018
Q4 | $356K | Sell |
4,200
-761
| -15% | -$64.5K | 0.23% | 106 |
|
|
2018
Q3 | $850K | Sell |
4,961
-80
| -2% | -$13.7K | 0.46% | 66 |
|
|
2018
Q2 | $652K | Hold |
5,041
| – | – | 0.37% | 77 |
|
|
2018
Q1 | $519K | Hold |
5,041
| – | – | 0.29% | 92 |
|
|
2017
Q4 | $431K | Sell |
5,041
-41
| -0.8% | -$3.51K | 0.23% | 106 |
|
|
2017
Q3 | $432K | Hold |
5,082
| – | – | 0.25% | 104 |
|
|
2017
Q2 | $385K | Hold |
5,082
| – | – | 0.23% | 110 |
|
|
2017
Q1 | $336K | Hold |
5,082
| – | – | 0.21% | 130 |
|
|
2016
Q4 | $322K | Buy |
5,082
+81
| +2% | +$5.13K | 0.22% | 124 |
|
|
2016
Q3 | $318K | Buy |
5,001
+320
| +7% | +$20.3K | 0.21% | 123 |
|
|
2016
Q2 | $348K | Buy |
4,681
+48
| +1% | +$3.57K | 0.24% | 114 |
|
|
2016
Q1 | $309K | Buy |
+4,633
| New | +$309K | 0.22% | 121 |
|